Physician profile
Paul Y Cunningham
NPI 1356582886
$25,180.34
in general payments reported to CMS, 2019-2025
75 companies · $2,797 in 2025
The $2,797 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,635 · 2020: $2,221 · 2021: $3,772 · 2022: $4,098 · 2023: $2,668 · 2024: $2,989 · 2025: $2,797.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,455.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,454.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $4,382.06 | 2019-2025 | Cardiomems, Ensite, Confirm Rx |
| Medtronic Vascular, INC. | $3,219.96 | 2019-2020 | |
| Amgen INC. | $2,070.08 | 2019-2025 | Repatha, Repatha |
| Novartis Pharmaceuticals Corporation | $1,493.95 | 2019-2025 | |
| Boston Scientific Corporation | $1,439.66 | 2019-2025 | Watchman Flx, Watchman Access System, Varithena Administration Pack |
| Medtronic, INC. | $1,415.78 | 2021-2025 | Hawkone, Linq II, Venaseal |
| Avinger INC. | $1,120.07 | 2019-2023 | Pantheris |
| E.R. Squibb & Sons, L.L.C. | $834.87 | 2019-2025 | Camzyos, Eliquis |
| Abiomed | $683.96 | 2023-2025 | Impella |
| Shockwave Medical, INC | $665.58 | 2021-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Smith+Nephew, INC. | $624.25 | 2022-2025 | Stravix, Grafix Pl, Renasys Touch |
| Siemens Medical Solutions USA, INC. | $583.77 | 2020-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $512.57 | 2019-2025 | Jardiance |
| Janssen Pharmaceuticals, INC | $462.91 | 2019-2022 | |
| Impulse Dynamics (USA) INC. | $416.00 | 2021-2023 | Optimizer |
Show all 75 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $394.32 | 2021-2024 | Verquvo |
| Inari Medical, INC. | $361.12 | 2021-2022 | |
| Pfizer INC. | $261.35 | 2019-2024 | |
| Esperion Therapeutics, INC. | $256.65 | 2020-2023 | Nexletol |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $252.42 | 2019-2025 | Lifevest |
| Actelion Pharmaceuticals US, INC. | $241.70 | 2019-2025 | Uptravi, Opsumit, Opsynvi |
| Atricure, INC. | $230.60 | 2024-2025 | Synergy Ablation System |
| Corindus INC. | $222.40 | 2019 | |
| Cvrx, INC. | $210.24 | 2019-2024 | Barostim Neo System |
| Sanofi-Aventis U.S. LLC | $193.63 | 2019-2022 | |
| Surmodics, INC. | $184.30 | 2022 | |
| Angiodynamics, INC. | $169.12 | 2021-2024 | Auryon Laser System 100-120 Vac |
| Vifor Pharma, INC. | $138.07 | 2019 | |
| Heartflow, INC. | $135.47 | 2019-2022 | |
| Regeneron Pharmaceuticals, INC. | $128.64 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $128.09 | 2019-2024 | Farxiga |
| Tactile Systems Technology INC | $122.93 | 2019-2024 | Entre Plus, Flexitouch Plus |
| Philips North America LLC | $117.40 | 2022 | |
| Venclose INC. | $90.88 | 2020 | |
| Elutia, INC. | $75.44 | 2021-2022 | |
| Biotronik INC. | $72.87 | 2019-2022 | |
| Kestra Medical Technology Services, INC. | $72.61 | 2024 | Assure Wcd |
| Regeneron Healthcare Solutions, INC. | $72.36 | 2019-2024 | Evkeeza |
| Imperative Care, INC | $67.31 | 2024 | Prodigy Catheter |
| Amarin Pharma, INC. | $66.97 | 2019-2020 | |
| Leo Pharma INC. | $62.95 | 2025 | Spevigo |
| G Medical Diagnostic Services, INC. | $59.54 | 2022-2023 | Cardiac Monitoring Suite |
| Endologix LLC | $55.44 | 2025 | Torus Stent Graft System, Endocross Device |
| Urgo Medical North America, LLC | $52.05 | 2023-2025 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap, Urgoclean Ag |
| Ge Healthcare | $51.50 | 2019-2023 | |
| Chiesi USA, INC. | $46.79 | 2019-2020 | |
| Biosense Webster, INC. | $45.94 | 2019 | |
| Lemaitre Vascular, INC. | $36.02 | 2023-2025 | Artegraft Vascular Graft, Hydro Lemaitre Valvulotome |
| Terumo Medical Corporation | $35.03 | 2022 | |
| Baxter Healthcare | $34.43 | 2023 | Coseal |
| Bardy Diagnostics, INC. | $30.00 | 2019-2020 | |
| Kowa Pharmaceuticals America, INC. | $29.93 | 2020 | |
| Cardiva Medical, INC. | $29.63 | 2024 | Savvywire |
| Lsi Solutions INC | $28.71 | 2022 | |
| Edwards Lifesciences Corporation | $28.02 | 2024 | Mitris Resilia Mitral Valve |
| Coloplast Corp | $26.92 | 2025 | |
| Biocompatibles, INC. | $26.17 | 2019 | |
| Bard Peripheral Vascular, INC. | $24.32 | 2021 | |
| Astellas Pharma US INC | $23.24 | 2021 | |
| Silk Road Medical, INC. | $21.60 | 2020 | |
| Lantheus Medical Imaging, INC. | $18.56 | 2019 | |
| Polynovo North America LLC | $18.54 | 2023 | |
| Inspire Medical Systems, INC. | $18.27 | 2025 | Inspire |
| Novo Nordisk INC | $18.21 | 2024 | Ozempic, Rybelsus |
| Biotissue Holdings INC. | $18.06 | 2024 | |
| Braemar Manufacturing, LLC | $17.86 | 2019 | |
| Irhythm Technologies, INC. | $16.08 | 2024 | Zio Monitor, Zio Xt Patch |
| Pacira Pharmaceuticals Incorporated | $15.79 | 2021 | |
| Preventice Services, LLC | $15.78 | 2019 | |
| Zoll Circulation INC | $15.50 | 2020 | |
| Cardiovascular Systems INC. | $14.98 | 2022 | |
| Genzyme Corporation | $14.68 | 2021 | |
| Acell, INC. | $13.03 | 2020 | |
| Lexicon Pharmaceuticals, INC. | $12.86 | 2023 | Inpefa |
| Allergan, INC. | $11.55 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Cunningham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.